Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03674437 · ClinicalTrials.gov registry record

Evaluation of an Online, Remote Cognitive Battery for Use in Cancer Survivorship

A clinical trial of Breast Cancer Survivors, sponsored by Memorial Sloan Kettering Cancer Center.

Active
Registry status
441
Enrollment target
1
Study location

NCT03674437 is a study of Breast Cancer Survivors that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 441 participants, below the 2,706-participant average among 8 other Breast Cancer Survivors trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03674437, a study of Breast Cancer Survivors, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.

ACTIVE NOT RECRUITING
Registry status
441 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to measure changes in cognitive (mental) function in cancer survivors using a brief, reliable, game-like set of tests that can be completed outside the clinic, as an alternative to traditional neurocognitive assessments. This set of computerized tests, the Cogsuite Assessment, is expected to improve our ability to identify cognitive impairments in people who have been treated for cancer, so that we can (1) learn more about which cognitive functions are affected by cancer treatment, and (2) guide that treatment more effectively.

Conditions Studied

Breast Cancer Survivors

Interventions

  • BEHAVIORAL Traditional Neurocognitive Assessments
  • BEHAVIORAL Online Cognitive Battery (Cogsuite)

Study Locations (1)

New York

  • Memorial Sloan Kettering Cancer Center - New York

Trial Details

FieldValue
Enrollment Target 441 participants
Start Date 2018-09-11
Est. Completion 2026-09

Sponsor

Memorial Sloan Kettering Cancer Center

1,884 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03674437

The ClinicalTrials.gov registry entry for NCT03674437 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 441 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,706-participant average among 8 other Breast Cancer Survivors trials with a reported enrollment target (84% lower). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Breast Cancer Survivors appearing as the primary indexed condition, and to 2 interventions - of which Traditional Neurocognitive Assessments is the first listed.

NCT03674437 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT03674437 about?

NCT03674437 is a clinical study titled "Evaluation of an Online, Remote Cognitive Battery for Use in Cancer Survivorship". The purpose of this study is to measure changes in cognitive (mental) function in cancer survivors using a brief, reliable, game-like set of tests that can be completed outside the clinic, as an alternative to traditional neurocognitive assessments. This set of computerized tests, the Cogsuite Asses...

What is the current status of trial NCT03674437?

This trial is currently active not recruiting. The enrollment target is 441 participants. The study started on 2018-09-11. Estimated completion is 2026-09.

What conditions does trial NCT03674437 study?

This clinical trial studies the following conditions: Breast Cancer Survivors.

What interventions are being tested in trial NCT03674437?

The interventions under investigation include: Traditional Neurocognitive Assessments (BEHAVIORAL), Online Cognitive Battery (Cogsuite) (BEHAVIORAL).

Who is sponsoring clinical trial NCT03674437?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03674437 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Breast Cancer Survivors

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Breast Cancer Survivors

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.